U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Search Results

Amoxicillin Oral Powder for Suspension
Status: Currently in Shortage
»Date first posted: 10/28/2022
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Aurobindo, USA (Reverified 12/02/2022)

Company Contact Information:
866-850-2876

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
125 mg/5mL (NDCs 65862-706-01, 65862-706-55, and 65862-706-80) On allocation. Demand increase for drug
200 mg/5mL (NDCs 65862-070-01, 65862-070-50, and 65862-070-75) On allocation. Demand increase for drug
250 mg/5mL (NDCs 65862-707-01, 65862-707-55, and 65862-707-80) On allocation. Demand increase for drug
400 mg/5mL (NDCs 65862-071-01, 65862-071-50, and 65862-071-75) On allocation. Demand increase for drug

Hikma Pharmaceuticals (Reverified 12/02/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
125 mg/5mL (NDCs 0143-9888-01, 0143-9888-15, and 0143-9888-80) Available for current customers. Demand increase for drug
200 mg/5mL (NDCs 0143-9886-01, 0143-9886-50, and 0143-9886-75) Available for current customers. Demand increase for drug
250 mg/5mL (NDCs 0143-9889-01, 0143-9889-15, and 0143-9889-80) Available for current customers. Demand increase for drug
400 mg/5mL (NDCs 0143-9887-01, 0143-9887-50, and 0143-9887-75) Available for current customers. Demand increase for drug

Sandoz (Reverified 12/01/2022)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
125mg/5mL 100 mL (NDC 0781-60-3946) Unavailable; limited supply in Q1 2023 Other
125mg/5mL 150 mL (NDC 0781-60-3955) Unavailable; limited supply in Q1 2023 Other
250 mg/5 mL 80 mL (NDC 0781-60-3958) Unavailable; limited supply in Q1 2023 Other
200 mg/5 mL 100 mL (NDC 0781-61-5646) Unavailable; limited supply in Q1 2023 Other
200 mg/5 mL 50 mL (NDC 0781-61-5652) Limited Availability Other
200 mg/5 mL 75 mL (NDC 0781-61-5657) Unavailable; limited supply in Q1 2023 Other
400 mg/5 mL 100 mL (NDC 0781-61-5746) Unavailable; limited supply in Q4 2022 Other
400 mg/5 mL 50 mL (NDC 0781-61-5752) Limited Availability Other
400 mg/5 mL 75 mL (NDC 0781-61-5757) Limited Availability Other
250mg/5mL 100 mL (NDC 0781-60-4146) Unavailable; limited supply in Q1 2023 Other
250mg/5mL 150 mL (NDC 0781-60-4155) Unavailable; limited supply in Q1 2023 Other
250mg/5mL 80 mL (NDC 0781-60-4158) Limited Availability Other

Teva Pharmaceuticals (Revised 12/02/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/5mL (NDCs 0093-4160-73, 0093-4160-76, and 0093-4160-78) On allocation Demand increase for the drug
250 mg/5mL (NDCs 0093-4155-73, 0093-4155-80, and 0093-4155-79) On allocation Demand increase for the drug
400 mg/5mL (NDCs 0093-4161-73, 0093-4161-76, and 0093-4161-78) On allocation Demand increase for the drug
Back to Top